Nasopharyngeal carcinoma (NPC):
FACING THE SURVIVAL FACTS
Nasopharyngeal carcinoma (NPC) is a distinct cancer with a unique etiology and prognosis. Key data, including progression-free survival and overall survival, highlight the poor outcomes of patients with recurrent/metastatic nasopharyngeal carcinoma (R/M NPC).
HEAD AND NECK CANCERS
1‑YEAR
PROGRESSION‑FREE
SURVIVAL
20%
R/M NASOPHARYNGEAL*1
METASTATIC OROPHARYNGEAL†2
76%
HPV+
39%
HPV-
91%
STAGE IV laryngeal‡3
*Results from a multicenter, randomized, open-label, phase 3 trial of patients with recurrent or metastatic nasopharyngeal carcinoma (N=362).
†Results from a retrospective analysis of patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer (N=108).
‡Results from a retrospective study of patients with laryngeal squamous cell carcinoma (N=211).
Watch Dr. Rosenberg discuss nasopharyngeal cancer, its unique subtype and histologic classification, as well as treatment and prognosis.
VIDEO SERIES
Definition, incidence, and risk factors
Classification and clinical presentation
A distinct cancer
